Search research articles
Contact Us
Filters
Showing results (31-40 of 79) with videos related to
Page
of 8
Sort By:
Cells
|
February 12, 2025
Circulating Tumor DNA Testing for Minimal Residual Disease and Its Application in Colorectal Cancer
Oluseyi Abidoye, Daniel H Ahn, Mitesh J Borad, et al.
International Journal of Cancer
|
November 9, 2017
Biweekly cisplatin and gemcitabine in patients with advanced biliary tract cancer
Daniel H Ahn, Josh Reardon, Chul W Ahn, et al.
Cancers
|
March 28, 2025
Sequential Treatment with Regorafenib and Trifluridine/Tipiracil ± Bevacizumab in Refractory Metastatic Colorectal Cancer in Community Clinical Practice in the USA
Daniel H Ahn, Tanios S Bekaii-Saab, Chengbo Yuan, et al.
Frontiers in Oncology
|
September 27, 2021
Maintenance Therapy in First-Line Gastric and Gastroesophageal Junction Adenocarcinoma: A Retrospective Analysis
Daniel Walden, Mohamad Bassam Sonbol, Skye Buckner Petty, et al.
Clinical Colorectal Cancer
|
May 31, 2018
Small Intestine Neuroendocrine Tumor in a Patient With MUTYH Adenomatous Polyposis-Case Report and SEER Analysis
Tiffany K Weidner, John T Kidwell, Amy E Glasgow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2026
Correction: Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study
Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, et al.
Cancer
|
August 18, 2017
Second-line treatment in patients with pancreatic ductal adenocarcinoma: A meta-analysis
Mohamad Bassam Sonbol, Belal Firwana, Zhen Wang, et al.
Therapeutic Advances in Medical Oncology
|
February 17, 2017
A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis
Daniel H Ahn, Kavya Krishna, Marlo Blazer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2024
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study
Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, et al.
Oncolytic Virotherapy
|
April 5, 2018
Oncolytic virotherapy in upper gastrointestinal tract cancers
Raquel Yokoda, Bolni M Nagalo, Mansi Arora, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 79) with videos related to
Sort By:
Page
of 8
Cells
|
February 12, 2025
Circulating Tumor DNA Testing for Minimal Residual Disease and Its Application in Colorectal Cancer
Oluseyi Abidoye, Daniel H Ahn, Mitesh J Borad, et al.
International Journal of Cancer
|
November 9, 2017
Biweekly cisplatin and gemcitabine in patients with advanced biliary tract cancer
Daniel H Ahn, Josh Reardon, Chul W Ahn, et al.
Cancers
|
March 28, 2025
Sequential Treatment with Regorafenib and Trifluridine/Tipiracil ± Bevacizumab in Refractory Metastatic Colorectal Cancer in Community Clinical Practice in the USA
Daniel H Ahn, Tanios S Bekaii-Saab, Chengbo Yuan, et al.
Frontiers in Oncology
|
September 27, 2021
Maintenance Therapy in First-Line Gastric and Gastroesophageal Junction Adenocarcinoma: A Retrospective Analysis
Daniel Walden, Mohamad Bassam Sonbol, Skye Buckner Petty, et al.
Clinical Colorectal Cancer
|
May 31, 2018
Small Intestine Neuroendocrine Tumor in a Patient With MUTYH Adenomatous Polyposis-Case Report and SEER Analysis
Tiffany K Weidner, John T Kidwell, Amy E Glasgow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2026
Correction: Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study
Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, et al.
Cancer
|
August 18, 2017
Second-line treatment in patients with pancreatic ductal adenocarcinoma: A meta-analysis
Mohamad Bassam Sonbol, Belal Firwana, Zhen Wang, et al.
Therapeutic Advances in Medical Oncology
|
February 17, 2017
A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis
Daniel H Ahn, Kavya Krishna, Marlo Blazer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2024
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study
Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, et al.
Oncolytic Virotherapy
|
April 5, 2018
Oncolytic virotherapy in upper gastrointestinal tract cancers
Raquel Yokoda, Bolni M Nagalo, Mansi Arora, et al.
Page
of 8